Mendelian Disorders of RANKL/OPG/RANK Signaling

Genetics of Bone Biology and Skeletal Disease

Volumn , Issue , 2013, Pages 309-324

  Whyte, Michael P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878252314     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-387829-8.00020-2     Document Type: Chapter

References (70)

1. Martin TJ Paracrine regulation of osteoclast formation and activity: Milestones in discovery. J Musculoskel Neuron Interact 2004, 4:243-253.
2. Boyce BF, Xing L Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 2008, 473:139-146.
3. Hughes AE, Ralston SH, Marken J, Bell C, MacPherson H, Wallace RG, et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 2000, 24:45-48.
4. Whyte MP, Hughes AE Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J Bone Miner Res 2002, 17:26-29.
5. Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, et al. Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med 2002, 347:175-184.
6. Sobacchi C, Frattini A, Guerrini MM, Abinun M, Pangrazio A, Susani L, et al. Osteoclast-poor human osteopetrosis because of mutations in the gene encoding RANKL. Nat Genet 2007, 39:960-962.
7. Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, et al. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet 2008, 83:64-76.
8. Whyte MP Paget's disease of bone (clinical practice). N Engl J Med 2006, 355:593-600.
9. Online Mendelian Inheritance in Man OMIM®. McKusick-Nathans Institute of Genetic Medicine 10.04.2012, Johns Hopkins University, Baltimore, MD, World Wide Web URL: .
10. Whyte MP, Mills BG, Roodman GD, Reinus WR, Podgornik MN, Eddy MC, et al. Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease. J Bone Miner Res 2000, 15:2330-2344.
11. Hughes AE, Barr J Familial expansile osteolysis: A genetic model of Paget's disease. The Molecular Biology of Paget's Disease 1996, 179-199. RG Landes, Heidelberg. P.T. Sharpe (Ed.).
12. Whyte MP, Reinus WR, Podgornik MN, Mills BG Familial expansile osteolysis (excessive RANK effect) in a 5-generation American kindred. Medicine (Baltimore) 2002, 81:101-121.
13. Enderle A, von Gumppenberg S Osteitis deformans (Paget) - or a tarda-type of a hereditary hyperphosphatasia. [German]. Arch Orthop Trauma Surg 1979, 94:127-134.
14. Enderle A, Willert HG Osteolytic-expansive type of familial Paget's disease (osteitis deformans). Pathol Res Pract 1979, 166:131-139.
15. Osterberg PH An unusual familial disorder of bone: Response to calcitonin. Bone Disease and Calcitonin 1976, 181-185. Armour Pharmaceutical Company, London. J.A. Kanis (Ed.).
16. RGH. Wallace, A study of a familial bone dysplasia. MD thesis. The Queen's University of Belfast, Northern Ireland, 1987.
17. Dickson GR, Shirodria PV, Kanis JA, Beneton MNC, Carr KE, Mollan RA Familial expansile osteolysis: a morphological, histomorphometric and serological study. Bone 1991, 12:331-338.
18. Barr RJ, Hughes AE, Mollan RA, Nevin NC Idiopathic multicentric osteolysis: report of two new cases and a review of the literature. [Letter]. Am J Med Genet 1989, 32:556.
19. Crone MD, Wallace RG The radiographic features of familial expansile osteolysis. Skeletal Radiol 1990, 19:245-250.
20. Mitchell CA, Kennedy JG, Owens PD Dental histology in familial expansile osteolysis. J Oral Pathol Med 1990, 19:65-70.
21. Mitchell CA, Kennedy JG, Wallace RG Dental abnormalities associated with familial expansile osteolysis: a clinical and radiographic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1990, 70:301-307.
22. Osterberg PH, Wallace RG, Adams DA, Crone RS, Dickson GR, Kanis JA, et al. Familial expansile osteolysis: a new dysplasia. J Bone Joint Surg Br 1988, 70:255-260.
23. Wallace RG, Barr RJ, Osterberg PH, Mollan RA Familial expansile osteolysis. Clin Orthop. 1989, 248:265-277.
24. Hughes AE, Shearman AM, Weber JL, Barr RJ, Wallace RG, Osterberg PH, et al. Genetic linkage of familial expansile osteolysis to chromosome 18q. Hum Mol Genet 1994, 3:359-361.
25. Lories RJU, Luyten FP Osteoprotegerin and osteoprotegerin-ligand balance: a new paradigm in bone metabolism providing new therapeutic targets. Clin Rheumatol 2001, 20:3-9.
26. Palenzuela L, Vives-Bauza C, Fernández-Cadenas I, Meseguer A, Font N, Sarret E, et al. Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. J Med Genet 2002, 39:e67.
27. Johnson-Pais TL, Singer FR, Bone HG, McMurray CT, Hansen MF, Leach RJ Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. J Bone Miner Res 2003, 18:376-380.
28. Esselman GH, Goebel JA, Wippold FJ Conductive hearing loss caused by hereditary incus necrosis: a study of familial expansile osteolysis. Otolaryngol Head Neck Surg 1996, 114:639-641.
29. Marik I, Marikova A, Hyankova E, Kozlowski K Familial expansile osteolysis - not exclusively an adult disorder. Skeletal Radiol 2006, 35:872-875.
30. Bacri D, Arush MW, Vlodavsky E, Kollander Y, Militianu D, Postovsky S Osteogenic sarcoma in a child with familial expansile osteolysis syndrome: an accidental association?. J Pediatr Hematol Oncol 2010, 32:e50-e53.
31. Crockett JC, Mellis DJ, Scott DI, Helfrich MH New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis. Osteoporos Int 2011, 22:1-20.
32. Crockett JC, Mellis DJ, Shennan KI, Duthie A, Greenhorn J, Wilkinson DI, et al. Signal peptide mutations in RANK prevent downstream activation of NFκB. J Bone Miner Res 2011, 26:1926-1938.
33. Nakatsuka K, Nishizawa Y, Ralston SH Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. J Bone Miner Res 2003, 18:1381-1385.
34. Ke YH, Yue H, He JW, Liu YJ, Zhang ZL Early onset Paget's disease of bone caused by a novel mutation (78dup27) of the TNFRSF11A gene in a Chinese family. Acta Pharmacol Sin 2009, 30:1204-1210.
35. Riches PL, Imanishi Y, Nakatsuka K, Ralston SH Clinical and biochemical response of TNFRSF11A-mediated early-onset familial Paget disease to bisphosphonate therapy. Calcif Tissue Int 2008, 83:272-275.
36. Albagha O, Rojas J, Van't Hof R, Dorin J, Ralston S A mouse model of early onset Paget's disease of bone caused by an insertion mutation affecting the RANK signal peptide. (abstract). Calcif Tissue Int 2007, 80:s39.
37. Olsen CB, Tanghaitrong K, Chippendale I, Graham HK, Dahl HM, Stockigt JR Tooth root resorption associated with a familial bone dysplasia affecting mother and daughter. Pediatr Dent 1999, 21:363-367.
38. Chosich N, Long F, Wong R, Topliss DJ, Stockigt JR Post-partum hypercalcemia in hereditary hyperphosphatasia (juvenile Paget's disease). J Endocrinol Invest 1991, 14:591-597.
39. Schafer AL, El-Sayed I, Mumm S, Anderson M, Hsiao EC, Schaefer F, et al. Panostotic high turnover bone disease with massive jaw tumor formation (abstract). J Bone Miner Res 2010, 25:S273.
40. Mumm S, Tau C, Zhang X, McAlister WH, Whyte MP Osteoprotegerin (OPG) deficiency mimicked by a novel 15-base pair tandem duplication in TNFRSF11A encoding RANK: merging the juvenile paget's disease and expansile skeletal hyperphosphatasia phenotypes (abstract). J Bone Miner Res 2008, 23:S134.
41. Van Hul W Identification of genetic modifiers of monogenic (bone) diseases: new tools available but with limitations. J Bone Miner Res 2011, 26:918-919.
42. Roodman GD, Windle JJ Paget disease of bone. J Clin Invest. 2005, 115:200-208.
43. Hamdy RC Paget's Disease of Bone: Assessment and Management 1981, Praeger Publishers, New York.
44. Kanis JA Pathophysiology and Treatment of Paget's Disease of Bone 1998, Blackwell Science, Malden, MA. 2nd ed.
45. Cole DEC, Whyte MP Hyperphosphatasia syndromes. Studies in Stomatology and Craniofacial Biology 1996, 245-272. IOS Press, Amsterdam. M.M. Cohen, B.J. Baum (Eds.).
46. Whyte MP, Singhellakis P, Petersen MB, Davies M, Totty WG, Mumm S Juvenile Paget's disease: the second reported, oldest patient is homozygous for the TNFRSF11B "balkan" mutation (966_969deltgacinsctt) which elevates circulating immunoreactive osteoprotegerin levels. J Bone Miner Res 2007, 22:938-946.
47. Golob DS, McAlister WH, Mills BG, Fedde KN, Reinus WR, Teitelbaum SL, et al. Juvenile Paget disease: life-long features of a mildly affected young woman. J Bone Miner Res 1996, 11:132-142.
48. Thompson, R.C., G.E. Gaull, et al. Hereditary hyperphosphatasia. Studies of three siblings. Am J Med. 47:209-219.
49. Eroglu M, Taneli NN Congenital hyperphosphatasia (juvenile Paget's disease). Eleven years follow-up of three sisters. Ann Radiol 1977, 20:145-150.
50. Temtamy SA, El-Meligy MR, et al. Hyperphosphatasia in an Egyptian child. Birth Defects Original Article Series 1974, 10:196-202.
51. Mitsudo SM Chronic idiopathic hyperphosphatasia associated with pseudoxanthoma elasticum. J Bone Joint Surg Am 1971, 53:303-314.
52. Horwith M, Nunez EA, et al. Hereditary bone dysplasia with hyperphosphatasaemia: response to synthetic human calcitonin. Clin Endocrin 1976, 5:S341-S352.
53. Salmon P Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone. J Bone Miner Res 2004, 19:695-702.
54. Woodhouse NJY, Fisher MT, Sigurdsson G, Joplin GF, MacIntyre I Paget's disease in a 5-year-old: acute response to human calcitonin. Br Med J. 1972, 4:267-269.
55. Reddy SV, Singer FR, Mallette L, Roodman GD Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget disease. J Bone Miner Res 1996, 11:1602-1607.
56. Whyte MP, Leelawattana R, Reddy SV, Roodman GD Absence of paramyxovirus transcripts in juvenile Paget bone disease [Letter]. J Bone Miner Res 1996, 11:1041.
57. Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, et al. A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Genet 2002, 11:2119-2127.
58. Mumm S, Banze S, Pettifor J, Tau C, Schmitt K, Ahmed A, et al. Juvenile Paget's disease: molecular analysis of TNFRSF11B encoding osteoprotegerin indicates homozygous deactivating mutations from consanguinity as the predominant etiology (abstract). J Bone Miner Res 2003, 18:S388.
59. 1990 Census of population and housing: characteristics of American Indians by tribe and language. Washington, DC: Bureau of the Census, 1994.
60. Whyte MP, Podgornik MN, Mumm S Osteoprotegerin and juvenile Paget disease (reply letter). N Eng J Med 2002, 347:1622-1623.
61. Chong B, Hegde M, Fawkner M, Simonet S, Cassinelli H, Coker M, International Hyperphosphatasia Collaborative Group, et al. Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. J Bone Miner Res 2003, 18:2095-2104.
62. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
63. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998, 12:260-268.
64. Silve C, Grosse B, Tau C, Garabedian M, Fritsch J, Delmas PD, et al. Response to parathyroid hormone and 1,25-dihydroxyvitamin D3 of bone-derived cells isolated from normal children and children with abnormalities in skeletal development. J Clin Endocrinol Metab 1986, 62:583-590.
65. Kerr NM, Cassinelli HR, DiMeglio LA, Tau C, Tüysüz B, Cundy T, et al. Ocular manifestations of juvenile Paget disease. Arch Ophthalmol. 2010, 128:698-703.
66. Allen CA, Hart BL, Taylor CL, Clericuzio CL Bilateral cavernous internal carotid aneurysms in a child with juvenile paget disease and osteoprotegerin deficiency. Am J Neuroradiol 2008, 29:7-8.
67. Kantaputra PN, Limwongse C, Koolvisoot A, Ausawamongkolkul A, Tayavitit S newly recognized polyosteolysis/hyperostosis syndrome. Am J Med Genet A. 2006, 140:2640-2645.
68. Cundy T, Davidson J, Rutland MD, Stewart C, DePaoli AM Recombinant osteoprotegerin for juvenile Paget's disease. N Engl J Med 2005, 353:918-923.
69. Pangrazio A, Cassani B, Guerrini MM, Crockett JC, Marrella V, Zammataro L, et al. RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations. J Bone Miner Res 2012, 27:342-351.
70. Gottesman G, Pena L, Yang C, Mumm S, Madson K, Novack D, et al. A toddler with a novel "osteoclast-poor" osteopetrosis. (Abstract Number 229) Presented at the 2012 Amnerican College of Medical Genetics Annual Clinical Genetics Meeting, Charlotte, North Carolina, March 28-30, 2012. Available at: <> Last accessed on: 10.01.2012. http://submissions.miracd.com/acmg/ContentInfo.aspx?conID=2672.